CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy | MicrobiomeTrials← Back to trialsNCT05467683
CO2 Reactivity as a Biomarker of Non-Response to Exposure-Based Therapy
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2022-11-02Est. Completion: 2026-12-01
Enrollment target: 600 participants Locations- Boston University, Boston, Massachusetts, United States
- The University of Texas at Austin, Austin, Texas, United States
Other microbiome trials you might be interested in
Gambling Disorder
The investigators assume that High-intensity transcranial Alternating Current Stimulation (HI-tACS) could improve gambli…
Shanghai, ChinaEst. completion Nov 30, 2026
Trichotillomania (Hair-Pulling Disorder)TrichotillomaniaHair Pulling DisorderHair PullingHair-Pulling Disorder
This research study is testing the effectiveness and safety of semaglutide (Wegovy) in people with trichotillomania, als…
Multiple LocationsEst. completion Feb 2027
Antipsychotic-induced Weight Gain (AIWG)Antipsychotic-induced Weight Gain
The goal of this clinical trial is to learn whether dapagliflozin can help manage weight gain caused by antipsychotic me…
Muscat, OmanEst. completion Nov 2028